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INTRODUCTION 
The human and economic impact of atherosclerotic vascular disease 
is formidable. The National Center for Health Statistics estimates 
that in 1978 almost 730,000 deaths, 38% of all deaths occurring in the 
United States that year, were attributable to atherosclerotic vascular 
disease or its direct complications (ischemic heart disease, cerebro¬ 
vascular thrombosis, and cerebral embolism)^. The American Heart As¬ 
sociation estimated the cost of cardiovascular disease in the United 
States to be approximately 28.5 billion dollars in 1978^, and it is 
recognized that atherosclerosis accounts for more than 60% of all car¬ 
diovascular disease^. Yet despite the intense effort and vast amount 
of money expended on research related to atherosclerotic disease there 
has been frustratingly meager advancement toward the statement of a 
comprehensive theoretical framework within which clinical and basic 
science questions concerning atherosclerosis may be addressed. However 
in the past decade primarily due to the work of Ross and Glomset and 
their colleagues in formulating and developing the response-to-injury 
hypothesis^»62,88-91 # progress toward the statement of a synthetic 
theory has been made. Already the response-to-injury hypothesis has 
permitted a more logical approach to major questions concerning the 
pathogenesis and progression of atherosclerosis such as the role of 
various risk factors, the natural history of vascular lesions, the 
origin and fate of incorporated lipids, the role of thrombosis in the 
disease process, the significance of the vascular smooth muscle cell, 
and the most promising modalities of prevention and treatment. 
This study presents an overview of the development of the response 
to-injury hypothesis, offers an up-to-date formulation of the patho- 
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physiological mechanisms postulated by this theory, and presents data 
collected during the course of my thesis research relevant to questions 
posed by this theory. 

3. 
A MODERN THEORY OF THE PATHOGENESIS OF ATHEROSCLEROSIS 
A. Background 
All modern theories of the pathogenesis of atherosclerosis find 
their origins in the nineteenth century works of von Rokitansky and 
Virchow. In 1852 von Rokitansky proposed that: 
"The [a theroscl erotic ] deposit cannot be regarded as 
a product (exudation) of an inflammation of the arteries... 
The deposit is an endogenous product derived from the blood 
and for the most part from fibrin of the arterial blood."86 
He postulated that through "metamorphosis" and degeneration these 
deposits evolve into advanced atherosclerotic plaques. In contrast 
Virchow viewed atheroma as the result of processes intrinsic to the 
vessel wall 10^. He claimed that irritation of the vascular endothelium 
results in a breakdown of the endothelial barrier, allowing infiltration 
of plasma constituents into the vessel wall. These insudated substances 
invoke a proliferative reaction of intimal connective tissue cells; 
reactive fibrosis in the overlying endothelium manifests itself as a 
fibrous cap covering the lesion. Mallory's demonstration of fibrin-like 
material in atherosclerotic lesions^ and Clarke et. al.'s study dis¬ 
playing a spectrum of lesions ranging from simple mural thrombi to endo¬ 
thelial ized clot-containing fibrous plaques^ gave further credence to 
the significance of thrombosis in the development of atherosclerosis. 
However, it wasn't until the 1940's that Duguid refocused attention on 
the thrombotic mechanisms proposed by von Rokitansky. Invoking hemo¬ 
dynamic arguments he refuted Virchow's then popular view of atheroma 
as arising from fibrous overgrowth of degenerative fatty medial lesions^ 
and cited his own work which demonstrated endothelia 1ization of mural 
thrombi and their subsequent organization into intimal plaques^ >25 as 
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evidence for the crucial role of thrombosis in the genesis of athero- 
sclerosis26’27. Investigations over the next twenty years49’66, es¬ 
pecially those looking at the role of fibrin deposition in the develop¬ 
ment of lesions47,79, intimal thrombosis39,53*'76,39, and a thromboembolic 
rabbit model of atheroscl erosi s42 reinforced the importance of thrombotic 
mechanisms in the inception and progression of atherosclerotic plaques. 
Concurrently, French emphasized the importance of endothelial structure 
and response29. Meanwhile Virchow's view of a proliferative medial 
response to intimal irritation was reawakened through studies39,3^>82-85,95 
demonstrating that endothelial injury or loss results in the growth of 
fibrous intimal plaques characterized by the proliteration of smooth 
muscle cells. These lesions are similar to the focal fibromuscular lesions 
seen in human atherosclerosis39’49’63. However, none of these experimental 
lesions evidenced the accumulation or incorporation of lipid, except in 
the presence of hypercholesterolemia94. Renewed interest in the smooth 
muscle cell response to endothelial injury developed with the recognition 
that delayed .re-endothel ial ization^ 9 or repeated endothelial injury64*66 
could lead to the development of lipid containing lesions in normolipemic 
animals. These findings stimulated further investigation which showed 
that endothelial injury is not merely an experimentally induced phenomenon 
but that it is an ongoing event in both animals9»12>53,80,102 and man46,53s 
and the sites where such injury is most often seen correspond to common 
loci of atherosclerotic disease. 
In 1973 Ross and Glomset reviewed the role of the smooth muscle cell 
in atherosclerosis, emphasizing that focal intimal accumulation of these 
cells is fundamental to the entire process of atherogenesis". Citing 
much of the evidence noted above, they highlighted the association of 
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endothelial injury with smooth muscle cell proliferation and the 
development of atherosclerosis. To explain this association they pos¬ 
tulated that "the intact arterial endothelium normally acts as a barrier 
to some substance or substances present in plasma which upon exposure 
to vascular smooth muscle promote cell pro! iferation". They made no 
mention of a possible relationship of thrombotic processes to smooth 
muscle cell proliferation. It was not until the following year, with 
the identification of a platelet dependent serum factor mitogenic for 
smooth muscle cells^ that the response-to-injury hypothesis emerged. 
B. The Response-to-injury Hypothesis^ 4,8 7 - go 
Endothelial Injury (Figure 1) 
Ross and Glomset posit intimal injury and the resultant focal 
endothelial desquamation as the initial events in atherogenesis. It 
is well established that endothelial injury or denudation resulting from 
almost any insul t"*0,14,28,30,45,81 ,82,85,94 will lead to the formation 
of fibrous plaques characterized by smooth muscle cell proliferation. 
That focal endothelial injury is a common phenomenon in animals and 
humans is also well documented^*! 2,46,53,102# Numerous factors have 
been identified as injury causing agents, including the interaction of 
hemodynamic forces and formed blood elements with the vessel wall 36>40^ 
hypertension-^’^ microbiologic agents!! *22,27s immunologic agents^, 
blood borne carbon monoxide derived from cigarette smoke and air pol¬ 
lution^, lipids and chol esterol 3,50,52,78,92, thrombin^, and inappro¬ 
priate concentrations of normal biologic metabolites^. Moore has re¬ 
viewed an extensive body of data and concluded that these factors are 
indeed operational in humans^. He notes the frequent occurrence of 
atherosclerotic lesions in human situations where these factors can 
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be implicated, including: (1) the association of atherosclerosis with 
the risk factors of hypertension, hyperl ipidemia, and cigarette smoking; 
(2) atherosclerotic lesions occurring in the walls of autologous vein 
grafts exposed to the relative hypertension of arterial pressure; 
(3) the occurrence of atherosclerosis in the arteries of transplanted 
organs which are constantly exposed to immunologic damage; (4) the 
high incidence of thromboembolic phenomena in homocystinurics; and 
(5) the frequent finding in autopsies performed on neonates who had intra¬ 
aortic catheters in place of atherosclerotic lesions near the 
location of the catheter tip. The final connection of endothelial injury 
to atherosclerosis is made by studies demonstrating that when the endo¬ 
thelial insult is repetitive or chronic the fibrous plaques will incor- 
porate and retain lipids * . 
Platelets and Plasma Constituents (Figures 2 and 3) 
Focal endothelial desquamation exposes subendothelia1 cells and 
connective tissue to platelets and other blood components. Ross and 
Glomset theorize that this blood-subendothelium interaction is respon¬ 
sible for the smooth muscle cell response to endothelial injury. Among 
blood constituents, lipoproteins^, insulin^6, and various hormones^9 
have been shown to stimulate the migration or proliferation of cells 
in vitro, and they may play a similar role in the in vivo stimulation of 
smooth muscle cells. Tissue thromboplastin released by damaged cells 
and collagen initiate the clotting cascade to generate thrombin7^. 
Although mitogenic for cultured fibroblasts thrombin probably does not 
stimulate smooth cells directly. However thrombin can alter the endo¬ 
thelial surface so that platelets will adhere to it^ and can stimulate 
platelet aggregation and degranulation^. 
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The most important blood borne mediator of the vascular response 
to injury is the platelet. Platelets adhere to the exposed subendo- 
thelial matrix, and their interaction with collagen induces platelet 
degranulation^. Among the substances released by platelet degranulation 
is a platelet dependent smooth muscle cell mitogen (PDSMCM) that was 
first identified by Ross, et. al.^ in 1 974. The PDSMCM is a heat 
stable basic protein released from platelet alpha-granules during de¬ 
granulation caused by thrombin, ADP, and other releasing agents. It 
is mitogenic for cultured smooth muscle cells^’^. The PDSMCM and 
perhaps other blood derived substances are presumed by Ross and Glomset 
to be the in vivo stimuli for smooth muscle cell migration and prolifera¬ 
tion subsequent to endothelial injury44>89-91. The critical in vivo 
role of platelets in the vascular response to injury is confirmed 
by studies showing the inhibition of fibrous plaque formation by the 
induction of thrombocytopenia^’^ or treatment with the anti-platelet 
drug dipyridamole^ prior to the causation of endothelial injury. 
Progression or Regression? (Figures 4 and 5) 
The response-to-injury hypothesis posits two alternative pathways 
for the evolution of an intimal injury. If the developing plaque is 
permitted to re-endothelialize regression of the lesion occurs (Figure 
4). Such regression is observed in many animal models involving a 
limited endothelial injury^»14,28,34,82,83,94,95. However, repeated 
or chronic bouts of endothelial injury can lead to continuing smooth 
muscle cell proliferation with lipid incorporation* (Figure 5); such 
* One can even envision a scenario whereby the initial injury and 
resulting smooth muscle cell proliferation, by creating a raised 
plaque protruding into the vessel lumen which is therefore 
subject to greater hemodynamic stresses, actually predisposes 
to further injury. 
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a progression is seen in a variety of animal model s33,^>65,67 . Con¬ 
tinued proliferation and lipid incorporation may also occur when endo¬ 
thelial injury synergizes with hyper! ipidemia3’^3,69,77. The synergistic 
effect of hyperl ipidemia may be due to a combination of factors including 
a direct stimulatory effect of lipids on smooth muscle cells33,an 
injurious effect of lipids on endothelium3,33,33,73,92} lipid induced 
platelet hypersensitivity33,37,75 (cigarette smoking also causes plate¬ 
let hypersensitivity7^), and an irritative effect of insoluble insudated 
cholesterol3®. Lipid accumulating in the lesion may be derived from 
either insudated serum lipids or from the smooth muscle cells themselves; 
this process is not well understood^. Regardless, once a lipid con¬ 
taining plaque is established the well characterized processes of throm¬ 
bosis and embolization can then act to lead to the development of com¬ 
plicated atherosclerotic plaques and overt clinical sequelae33,37 ,z*3, 73,/Cr. 
Summarizing, the response-to-injury hypothesis postulates endo¬ 
thelial injury as the initiating factor in atherogenesis, smooth muscle 
cell proliteration and migration in response to the PDSMCM and other 
serum factors as the initial vascular response, and either regression 
of the proliferative lesion or progression in the face of continuing 
intimal insult to an atherosclerotic plaque. The theory accounts 
for many experimental and clinical observations concerning athero¬ 
sclerosis, including the role of endothelial injury, the significance 
of smooth muscle cell proliferation, the importance of platelets and 
thrombosis, and the association of certain risk factors with clinical 
disease patterns. As Ross and Glomset are quick to note however, 
there are gaps in the hypothesis. It does not in its present form 
answer questions regarding the differential incidence and severity 
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of atheroscl erosis among individuals and population groups. The 
mechanisms of plaque regression, lipid incorporation, and other details 
concerning the role of lipids are not specified. The significance of 
the observations of Benditt and Benditt suggesting .that the prolifera¬ 
tion of smooth muscle cells is monoclonal is not addressed. Many 
details of the theory also remain to be elucidated, including a further 
characterization of the biology and surface characteristics of the 
smooth muscle cells, a more complete characterization of the PDSMCM 
and other possible mitogens, the role of thrombin and other coagulation 
factors in the response to injury, determination of the detailed 
mechanism of platelet function at the injury site, and the identifica¬ 
tion of pharmacological agents that may be used to selectively alter 
the response to injury in both research and clinical settings. 
C. This Investigation 
The objectives of this study are threefold: (1) to confirm the 
validity of a model recently developed to investigate the vascular 
response to endothelial denudation in the rat; (2) to further charac¬ 
terize observations made with this model; and (3) to use this model 
to obtain new data regarding the role of thrombin in the response to 
intimal injury. 
The use of this model was first reported by Fishman, et. al.28; 
they adapted it from a technique employed to study the injury response 
of peritoneal mesothel ium93 and have since used the model extensively^-^. 
It involves induction of endothelial desquamation and resultant fibrous 
plaque formation through creation of a desiccating injury in the rat 
carotid artery. This model was selected for use in this investigation 
for several reasons: (1) as a potentially valuable technique for 
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the study of myointimal response to vascular injury it warrant fur¬ 
ther characterization; (2) the endothelial denudation produced is com¬ 
plete and occurs in a well defined segment of artery; (3) in contrast 
to other techniques used to create intimal injury^’^’3^ 31 ,46,64,65 , 
81 -85,94,95,97 there is no metabolic or mechanical insul t33 ’^4 to 
the media; the injury is purely endothelial; (4) the rat is a well 
characterized and inexpensive experimental model; and (5) pharmacologic 
intervention in rats is relatively simple. 
The effect of aspirin on the vascular response to injury was in¬ 
vestigated because of its well known effects on platelets'll and because 
of the attention it has received as a possible treatment and/or pro¬ 
phylaxis for clinical cardiovascular disease'73. This aspect of the 
study repeats investigations made elsewhere3’!3. 
Interest in,the role of thrombin in the myointimal response to 
injury suggested that the effect of an anti-thrombin agent on the 
model be studied. Heparin has previously been shown to blunt the pro¬ 
liferative response to injury and it was speculated that this effect 
may be due to heparin inhibition of thrombin formation^. However, the 
pharmacological activities of heparin are complex and varied. To more 
clearly elucidate the role of thrombin in the injury response the 
effect of warfarin, a drug whose effects are limited solely to its 
inhibition of synthesis of the vitamin K dependent clotting factors 




Fifty-eight male Sprague-Dawley rats, each weighing 175 to 250 
grams, were obtained from Camm Research Institute (Wayne, New Jersey). 
All rats were allowed free access to Purina Rodent Laboratory Chow 
5001 (Ralston Purina Company, St. Louis, Missouri) and water at all 
times. Assignments to experimental groups were made randomly. Twenty 
rats were assigned to the control group, fourteen to the aspirin group, 
and twenty-four to the warfarin group. 
Operation 
All operations were carried out under ether anesthesia and involved 
the creation of a desiccating injury to the left common carotid artery 
endothelium according to the method of Fishman, et. al.^. Briefly 
(see Appendix for a detailed 'op-note'), the procedure involved ex- 
i 
posure of a 2.5 - 3.5 cm. unbranched segment of left common carotid 
artery through a midline cervical incision. Two 4-0 silk ligatures 
were tied tightly around the artery approximately 2 cm. apart. A 
30-gauge needle attached via a connecting tube and three-way stopcock 
to a syringe containing normal saline and a syringe containing 60 ml. 
of room air was then inserted into the lumen of the isolated arterial 
segment just distal to the proximal ligature and passed along the lumen, 
carefully avoiding contact with the vessel wall. The needle was ad¬ 
vanced to a point just proximal to the distal ligature where it was 
allowed to penetrate the full thickness of the vessel wall. It was 
then withdrawn back through the lumen until only the tip remained 
intraluminal and used to rinse the isolated segment with approximately 
0.5 ml. of saline. Next the stopcock valve was switched and the 60 ml. 
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of air was streamed gently through the lumen at a rate of 30 ml. per 
minute to produce the desiccating endothelial injury. The lumen was 
then refilled with normal saline and the ligatures removed. Hemostasis 
was achieved with gentle pressure applied to the needle holes with 
dry or saline moistened gauze sponges; hemostasis was generally at¬ 
tained in less than three minutes in the control and aspirin treated 
rats but often required 7-10 minutes in the warfarin treated rats. The 
skin incision was closed with a single layer of interrupted 4-0 silk 
sutures. 
Carotid artery specimens for histological examination were obtained 
via re-operation through the original incision under ether anesthesia. 
The left common carotid artery was again isolated, 4-0 silk ligatures 
placed proximally and distally, and the isolated (previously desiccated) 
segment resected using a small dissecting scissors and small blunt 
forceps. The sample was immediately rinsed in normal saline and placed 
in formalin. With the rat still alive a 2-3 ml. blood sample was then 
obtained via cardiac puncture with a 23-gauge needle for clotting time 
determination. 
Pharmacological Protocol 
Control group rats received no pre-operative or post-operative 
treatment. Two rats were sacrificed without undergoing the desiccation 
procedure (Day 0) and two each were sacrificed on the first, third, 
fifth, seventh, tenth, twenty-first, and twenty-eighth post-operative 
days. Three control rats were sacrificed on the fourteenth post-operative 
day. (Tabl e 1) 
The aspirin treated rats received 160 mg. per kg. of powdered 
aspirin (McKesson) suspended in glycerin U.S.P. to,a concentration of 
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50 mg. per ml. The aspirin suspension was administered via gavage 
through a 16-gauge dosing needle 24 hours pre-operatively, immediately 
pre-operatively, and then each morning post-operatively until sacrifice. 
Three rats were sacrificed on each of the post-operative days 7, 14, 
21 and 28. (Table 1) 
The warfarin group rats received 0.1 mg. per kg. of warfarin 
(Endo) dissolved in tap water to a concentration of 0.05 mg. per ml. 
and administered via gavage through a 16-gauge dosing needle. The 
rats were dosed 12 hours pre-operatively, immediately pre-operatively, 
36 hours post-operatively, and then each morning until sacrifice. Two 
rats were sacrificed on the seventh post-operative day, and three each 
on the fourteenth and twenty-eighth post-operative days. (Table 1) 
Clotting Times 
Clotting times were determined from 1 ml. samples of whole blood 
according to the method of Lee and White^ to the nearest half-minute. 
Control samples were obtained from age and weight matched male Sprague- 
Dawley rats attained from Camm Research Institute. 
Microscopy 
Tissue specimens for light microscopy were fixed in formalin 
for at least 48 hours, embedded in paraffin, and sectioned. Sections 
were obtained from two to four longitudinally arrayed locations along 
the injured segment of artery. Sections were stained with hematoxylin 
and eosin or according to the Elastin-Van Giemsa method. 
Intima:media (I/M) ratios were determined by recording for each 
section of each specimen the maximal ratio of intimal thickness 
(distance from the luminal surface to the internal elastic lamina) 
to medial thickness (distance from the internal to the most external 
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elastic lamina) as measured with an optical graticule, and averaging 
these ratios for the sections to arrive at an average I/M ratio for 
each particular specimen. For each sample day a weighted average of 
these specimen averages ± S.E.M. was calculated. (All I/M ratios ± 
S.E.M. cited in this text are x 100.) Sections were scored only if 
there was no evidence of luminal or mural thrombosis, the boundaries 
of the intima and media were clearly demarcated, and the internal 
elastic lamina was intact. Control and experimental group means were 
compared using Student's t-test and hyperplasia growth rates were com¬ 




Of the 20 control group rats one developed thrombosis of its 
left common carotid artery and was discarded. All control group rats 
gained weight and thrived. One of the 14 aspirin group rats died 
for no apparent reason on the third post-operative day and one developed 
thrombosis of its left common carotid artery; all others gained weight, 
thrived, and completed the study. Sixteen of the 24 rats in the war¬ 
farin group died in the period two to nine days post-operatively, ap¬ 
parently secondary to bleeding diatheses. Of the eight animals surviving 
to completion of the study four evidenced some weight loss and four 
demonstrated weight gain and thrived. 
Clotting Times 
The clotting times of the control rats and the aspirin treated rats 
did not differ significantly (Table 2). The warfarin dosage used in 
this study was sufficient to significantly prolong the clotting time 
of the warfarin treated rats in comparison to those of both the control 
group (2.8 ± 0.5 min. vs. 1.3 ± 0.2 min.; p < 0.05) and the aspirin 
group (2.8 ± 0.5 min. vs. 1.5 ± 0.1 min.; p < 0.05) (Table 2). 
Histology 
Control Group - The observations confirmed those reported by 
Fishman, et. al.^®. Pre-operatively (Photograph 1) there is a mono- 
layer of delicate endothelial cells with elongated nuclei oriented 
parallel to the vessel wall overlying a densely populated dormant 
appearing media. At Day 1 post-operatively (Photograph 2) the endo¬ 
thelium is completely denuded exposing the internal elastic lamina. 
The innermost layers of the media evidence some edema. At Days 3 and 
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5 the medial edema has increased to encompass the full thickness of 
the media giving it a vacuolated appearance in both the hematoxylin 
and eosin and the Elastin-Van Giesma slides. Occasional medial mitoses 
are seen. There are no endothelial cells visible in Day 3 slides but 
by Day 5 endothelial regeneration is evidenced by the appearance of 
an occasional randomly oriented endothelial cell with a swollen nucleus. 
Occasional disruptions in the internal elastic lamina are noted, probably 
secondary to needle trauma. 
Day 7 marks the onset of myointimal proliferation. Layers of 
swollen endothelium two to four cell layers thick now cover many portions 
of the formerly exposed internal elastic lamina. In some areas pro¬ 
liferating myointimal cells insinuate themselves between the endothelium 
and the internal elastic lamina. Medial edema persists and mitoses are 
still observed in the media. Over the following fourteen days (Photo¬ 
graphs 3-5) myointimal and endothelial proliferation continue, peaking 
sometime between Days 10 and 21. In many specimens myointimal prolifera¬ 
tion is the predominant feature, occasionally creating plaques 20 to 30 
cells layers thick coated by swollen endothelial cells. This prolifera¬ 
tion is not uniform in transverse sections of vessels, leaving some 
areas untouched (Photograph 8), but it is regular along the length of 
the vessel. Elastin-Van Giesma stained slides show the plaques to be 
virtually overrun with elastin fibers. During this period the medial 
edema begins to resolve and mitoses become infrequent. By Day 28 
(Photograph 6) the hyperplastic myointima is beginning to recede re¬ 
sulting in a decrease in the average I/M ratio.. Most of the medial 
edema has resolved. 
At no time during this process is there evidence of medial in- 
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filtration or adherence to the denuded internal elastic lamina by 
polymorphonuclear leukocytes or other inflammatory cells. Myointimal 
hyperplasia is often most pronounced where the internal elastic lamina 
is interrupted, but these sites were not used in the determination of 
I/M ratios. 
Aspirin Group - The observations confirm those of Clowes, 
et. al.l^. They differed from the observations made on the control 
specimens in only two respects: 1) the maximal myointimal response 
is not seen until Day 21 (Photographs 7-9), somewhat later than in 
the control group; and 2) in three of the aspirin treated rats (one 
sacrificed on Day 21 and two on Day 28) very localized areas of strik¬ 
ing myointimal proliteration occurs giving the appearance of intra¬ 
luminal polyps (Photographs 10 and 11). These "polyps" are endothelial 
coated outgrowths of myointima, occasionally growing in whorled patterns, 
resting on intact internal elastic laminae. The myointimal cells are 
benign in appearance. 
Warfarin' Group - Throughout the observation period the changes 
in the media of warfarin treated rats parallel those seen in control 
group rats; edema is evident but no inflammatory infiltrate is noted. 
However, differences in endothelial regeneration and myointimal pro¬ 
liferation are noted. Regenerating endothelium in the warfarin group 
rats resembled normal endothelium, for the most part lacking the swelling 
and disorientation seen in the control and aspirin groups. Furthermore, 
although the peak I/M ratio in the warfarin treated rats is no different 
from that seen in the control group (Photographs 12 and 13), the hyper¬ 
plastic myointima resolves more quickly in the warfarin treated group 
(Photographs 14 and 15), resulting in a significantly lower I/M ratio 
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in Day 28 warfarin group rats than in Day 28 control rats (16.2 ± 2.2 
vs. 26.0 ± 3.3 respectively, d < 0.05). 
Intima/Media Ratios 
The I/M ratios observed are summarized in Table 3. Comparisons 
of the control group data with the aspirin group and warfarin group 
data are made in Graphs 1 and 2 respectively. The hyperplasia in the 
control group is seen to peak on Day 10 at an I/M value of 77.8 ± 21.0. 
The aspirin treated group did not achieve its peak I/M value until 
Day 21, when it was 130.2 ± 50.5. Maximum hyperplasia was observed 
in the warfarin group on Day 14 with an I/M ratio of 44.5 ± 26.8. 
These data confirm the histologic impression of the occurrence of 
significant hyperplasia in the control and aspirin groups. At all times 
beyond Day 6 the I/M ratios seen in control and aspirin group rats 
differ significantly from that seen in unoperated controls (p < 0.05; 
Table 4). No significant difference can be demonstrated between the 
I/M ratio observed in unoperated controls and the warfarin group at 
Days 7 and 14, although a statistically significant difference is noted 
at Day 28 (16.2 ± 2.2 vs. 8.7 ± 1 .5; p < 0.05; Table 4). 
18 
These findings also confirm the observations of Clowes, et. al. 
that aspirin does not affect the rat carotid artery myointimal response 
to desiccating endothelial injury. There are no significant differences 
in the I/M ratios at corresponding times between the control and aspirin 
groups (Table 3, Graph 1). Linear regression analysis reveals no sig¬ 
nificant difference in the rate of increase of the I/M ratios in the 
control and aspirin groups. 
There is no significant difference between the I/M ratios deter¬ 
mined in the control and warfarin groups at Days 7 and 14 but there is 
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a statistically significant greater degree of hyperplasia in the control 
group than in the warfarin group at Day 28 (26.0 ± 3.3 vs. 16.2 ± 2.2; 
p < 0.05; Table 3, Graph 2). Again linear regression analysis reveals 
no significant difference in the rate of growth of'the I/M ratios in the 




Under these experimental conditions carotid artery endothelial 
denudation leads to myointimal thickening characterized by smooth 
muscle cell proliferation and elaboration of connective tissue. This 
finding concurs with those of numerous other investigators who have 
studied this response. The histologic appearance and evolution of the 
lesions is also similar to that reported by other groups^’^*» 
81 ,82,94,95. jn particular this study confirms results obtained by 
70 
Clowes et. al. using this same experimental model. 
The chronology of development of the features observed in this 
00 
study is quite similar to that previously reported . By twenty-four 
hours after desiccation endothelial denudation is uniformly complete 
and medial edema is apparent. Day 7 marks the onset of myointimal 
hyperplasia by light microscopic criteria and frequent medial smooth 
muscle cell mitoses are evident. Peak myointimal thickening is ob¬ 
served near Day 14. Throughout the period of observation, for reasons 
not apparent, the myointimal response is noted to be circumferentially 
irregular. In contrast to observations previously reported °* °, in 
the current study medial edema persists through Day 28 and the re¬ 
generating endothelial cells lack the usually well-defined nuclear 
orientation seen in undisturbed endothelium. These differences are 
not deemed conceptually significant. For no apparent reason the 
magnitude of the I/M ratios observed in this study in all groups is 
less than those reported by Clowes et. al. * by a factor of ap¬ 
proximately ten. 
Observations made on the aspirin treated rats also confirm those 
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made elsewhere^, again with the exceptions of the persistence of 
medial edema and the irregular orientation of endothelial cell nuclei. 
Additional observations made in the aspirin group in the course of 
this study include: (1) delay of the peak myointimal response until 
Day 21, but because of the marked biological variability seen it is 
difficult to attribute this to an effect of aspirin; and (2) the for¬ 
mation of benign polypoid outgrowths of neointima seen only in aspirin 
treated rats; their significance is not known. 
The warfarin treated rats exhibit several important deviations 
from the findings seen in untreated rats. No statistically significant 
difference can be demonstrated between the I/M ratios observed in 
Day 7 and Day 14 warfarin group rats and unoperated control group rats, 
although there are clear histologic differences; and the magnitude 
of myointimal hyperplasia seen at Day 28 in warfarin treated rats is 
statistically significantly less than that seen in the control group 
rats. Both of these findings indicate that warfarin has a suppressive 
effect on the smooth muscle cell response to endothelial injury. 
The absence of an aspirin effect on the myointimal response to 
vessel wall injury is in agreement with previous reports on rat^ and 
rabbit^ models. It is understandable in light of current concepts 
regarding the mechanisms of platelet interaction with denuded vessel 
wall and the pharmacologic actions of aspirin. As summarized by 
Mustard, et. al.^3»74 endothelial injury results in platelet adherence 
to damaged endothelium and exposed subendothelial structures. Sub- 
endothelial collagen stimulates platelet granule release and in 
conjunction with tissue thromboplastin derived from damaged cells 
activates the coagulation cascade. Generated thrombin, platelet 
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released ADP, and endoperoxides PGG2 and PGH2 and thromboxane A2 
formed via the arachidonate pathway cause additional platelet ad¬ 
herence, recruitment of blood borne platelets (aggregation), and 
platelet granule release. Platelet adherence to collagen and col¬ 
lagen stimulated platelet degranulation are independent of the arachi¬ 
donate pathway^. Collagen dependent aggregation is in part mediated 
via the arachidonate pathway^. Platelet degranulation results in 
the release of the PDSMCM^»91 . 
It has been shown that after the initial adherence of a platelet 
monolayer to denuded vessel wall little subsequent platelet turnover 
or aggregation occur^1 and fibrin formation is minimal^, indicating 
that the critical events are the initial events of adherence and de¬ 
granulation. This concept receives further support from a study show¬ 
ing that to inhibit fibrous plaque formation thrombocytopenia must be 
induced prior to endothelial injury^. Aspirin affects thrombus for¬ 
mation by blocking the formation of PGG2, PGH2, and thromboxane A2, 
through the arachidonate pathway^. Therefore while aspirin inhibits 
platelet aggregation it does not affect platelet adherence to sub- 
endothelial structures or platelet degranulation. Thus it has no 
effect on the processes felt to be necessary for release of the PDSMCM. 
The expectation that a drug which inhibits platelet adherence and de¬ 
granulation should reduce the extent of fibrous plaque formation is 
confirmed by a study looking at the effect of dipyridamole in homo- 
cystinemic baboons^. 
The effect of warfarin on the vessel response to injury is almost 
certainly related to its suppression of the synthesis of the vitamin K 
dependent clotting factors (prothrombin, VII, IX, and X), as it is 
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largely devoid of other pharmacological activity88. In particular, 
its suppressive effect is probably mediated through its inhibition of 
thrombin formation. However, the details of this effect can only be 
conjectured as the role of blood coagulation in the response of the 
vessel wall to injury is not well defined. 
It is known that thrombin stimulates platelet aggregation and 
degranulation through mechanisms at least partly independent of ADP 
and the arachidonate pathway^. Thrombin induced degranulation causes 
release of the PDSMCM^. Additionally, exposure of intact endothelium 
to thrombin alters it such that it will permit adhesion of platelets . 
Thus, within the framework of the response-to-injury hypothesis, fac¬ 
tors which inhibit thrombin formation might be expected to blunt the 
smooth muscle cell response by: (1) inhibiting the thrombin mediated 
pathway that leads to release of the PDSMCM; and (2) inhibiting thrombin 
induced endothelial injury and the resultant platelet adhesion. 
In support of the importance of thrombin to the smooth muscle 
cell response to injury is evidence showing marked suppression of the 
response by heparin^. However, it is impossible to determine from 
that study whether the suppression is a result of the antithrombin 
activity of heparin or one of its many other biological actions. As 
a strong cation heparin may bind the basic PDSMCM^. Heparin inhibits 
wound healing in a variety of situations and may somehow alter the 
smooth muscle cell response through a similar effect on endothelial 
injury^. The binding of heparin to negatively charged subendothel ia 1 
structures88 may alter platelet-subendothelium interactions, although 
this is not morphologically apparent"*^. Heparin may similarly bind to 
the negatively charged platelet surface88 and inhibit platelet surface 
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interactions. Lipoprotein lipase, a vessel wall associated enzyme that 
clears chylomicrons and fatty acids from blood and that decreases plate¬ 
let adhesiveness is released by heparin and may thus influence both 
platelet activity and local lipid effects^. 
Because the only pharmacologic action shared by heparin and war¬ 
farin is inhibition of thrombin formation it is reasonable to speculate 
that their similar suppressive effect on the vascular response to in- 
timal injury is mediated by this anti-thrombin activity. Of course 
the possibility that warfarin exerts its effect solely through its 
inhibition of the synthesis of clotting factors VII, IX, and X and that 
the heparin suppression is independent of its anti-thrombin activity 
cannot be excluded at this time. If indeed both drugs do act through 
an anti-thrombin mechanism, this indicates a central role for thrombin 
in the response-fo-injury hypothesis. Thrombin may exert its influence 
through some combination of its effects on endothelium and platelet 
function. More speculatively, the demonstration of the mitogenicity of 
the PDSMCM for smooth muscle cells was carried out in the presence of 
thrombin^ and perhaps the proteolytic action of thrombin is necessary 
to activate the PDSMCM or to alter smooth muscle cell surface receptors 




This study used a rat model of desiccating carotid artery endo¬ 
thelial injury to examine the vessel response to endothelial denudation 
and to look at the effect of aspirin and warfarin on this response. 
While aspirin had no apparent effect warfarin reduced the magnitude 
of the myointimal response. It is conjectured that this is indicative 
of an important but as yet undetermined role for thrombin in vascular 
response to injury. This has important implications for the role of 
thrombin in the response-to-injury hypothesis of atherogenesis. 
■ 
26. 
APPENDIX: OPERATIVE NOTE 
After anesthetization to unresponsiveness in an ether chamber 
the rat was placed on a wooden surgical board and secured by its 
extremities. A rolled up 4 x 4 gauze was placed under the animal's 
neck to attain cervical extension. Anesthesia was maintained through¬ 
out the procedure with an ether soaked gauze sponge placed in a 50 ml. 
beaker near the rat's snout; anesthetic depth was regulated by varying 
the distance of the beaker from the snout and monitored by frequent 
observation of respiratory pattern and responsiveness to intra-operative 
stimuli, with special attention to frequently occurring laryngospasm. 
With the animal properly positioned the anterior neck was shaved 
and a midline incision made with a #11 knife blade from a point just 
superior to the hyoid bone to a point approximately 1/2 cm. superior 
to the sternal notch. Using blunt and sharp dissecting techniques 
the fascia joining the submaxillary glands across the midline was 
divided; the submaxillary glands were freed from underlying attachments 
and retracted laterally under the tension of a pair of small hemostats. 
Next the sternohyoid muscles were divided longitudinally in the midline 
via blunt dissection and retracted with a small self-retaining retractor 
to.expose the trachea. A small curved hemostat and a pair of small 
pointed forceps was used to locate the left common carotid artery by 
sliding along the left margin of the trachea (Photograph 17). An 
unbranched 3 cm. segment was freed up. Two 4-0 silk ligatures were 
placed around the artery such that they isolated a 2 cm . segment and 




Next, using a x2 magnifying visor and the proximal ligature to 
manipulate the artery, a 30-gauge needle attached to two 50 ml. syringes 
with a connecting tube and three-way stopcock (Photograph 19) was inserted 
into the proximal portion of the isolated segment,'Carefully passed up 
through the lumen, and then allowed to penetrate the full thickness 
of the vessel wall just proximal to the distal ligature. To prevent 
tearing the vessel this distal puncture was made while using surround¬ 
ing muscle tissue to "back" the arterial wall and thus support it. The 
needle was then carefully withdrawn such that only its tip remained 
intraluminal (Photograph 20). The air filled syringe was depressed so 
that the 0.5 ml. of normal saline filling the connecting tube rinsed 
the lumen and then a gentle stream of air (30 ml. per minute) was 
passed through the lumen for two minutes to cause the desiccating injury. 
When this was completed the stopcock was switched to permit refilling 
of the lumen with normal saline from the saline syringe and the needle 
was fully withdrawn. The distal ligature was removed and hemostasis 
achieved with gentle pressure from a combination of moist and dry 
gauze sponges, and then the proximal ligature was removed with bleeding 
controlled similarly (Photograph 21). 
Before closing the neck was rinsed thoroughly with normal saline 
and the sternohyoids were reapproximated with a non-absorbable 4-0 
silk suture to assist anatomical orientation at the time of specimen 
recovery. The skin was closed with interrupted 4-0 silk sutures (Photo¬ 
graph 22). Approximately two thirds of the rats undergoing this pro¬ 
cedure had a left Horner's Syndrome post-operatively, but otherwise 
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Endothelial injury, which may be caused by many dif¬ 
ferent forms of injury, exposes the sub-endothelium 
to platelets and other blood components (89). 

FIGURE 2 
A monolayer of platelets adheres to the exposed suben¬ 
dothelium. Collagen in the sub-endothelium stimulates 
the platelets to degranulate, releasing a variety of 
factors including the platelet dependent smooth muscle 
cell mitogen (89). 

FIGURE 3 
Smooth muscle cells migrate from the media into the in- 
tima through fenestrae in the internal elastic lamina 
and proliferate in response to platelet factors and 




Regression of the proliferative lesion shown in Figure 3 
occurs if the source of endothelial injury disappears, 
leaving a slightly thickened intima containing a few 
layers of smooth muscle cells (89). 

FIGURE 5 
Progression of the proliferative lesion shown in Figure 3 
occurs if the source of endothelial injury is chronic or 
recurrent, resulting in a proliferative lesion of cells 
and connective tissue in a pool of lipid. Thrombosis 
may cause further development into a complicated athero¬ 
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I/M RATIO x 100 
v i i i 
ASPIRIN WARFARIN 
DAY CONTROL 160 mq/kq/da.y 0.1 mq/kq/day 
0 8.7 ± 1.5 
(4)* * 
— — 






5 12.2 ± 4.4 
(4) 
— 
7 21.5 ± 1.5 
(4) 
17.4 ± 2.3 
(5) 
11.2 ± 3.2 
(2) 
10 77.8 ± 21.0 
(6) 
— — 
14 21o0 ± 4o6 
(8) 
33.8 ± 6.3 
(12) 
44.5 ± 26.8 
• (10) 
21 34.8 ± 3.7 
(6) 
130.2 ± 50.5 
(12) 
— 
28 26.0 ± 3.3 
(5) 
60.0 ± 18.1 
(10) 
16.2 ± 2.2 
(8) 
TABLE 3 
INTIMA/MEDIA RATIOS: I/M ratios ± S.E.M. x 100 in injured carotid 
arteries at various time points. Day 0 is 
the day of operation.* Day 0 control values 
are for uninjured vessels. 
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PHOTOGRAPH 1: Day 0 (unoperated) control. One endothelial cell 
nucleus is visible in the center, lying upon the internal elastic 
lamina. (Hematoxylin and Eosin, x 450; Lumen - Upper left) 
PHOTOGRAPH 2: Day 1 control. Note the absence of endothelial cell 
nuclei. (Hematoxylin and Eosin, x 450; Lumen - Left half) 

XI 11 
PHOTOGRAPH 3: Day 10 control. Marked myointimal hyperplasia is 
apparent. Note the medial edema. (Hematoxylin and Eosin, x 450; 
Lumen - Upper center) 
PHOTOGRAPH 4: Day 10 control. Note the copious amount of con¬ 
nective tissue in the neointima. (Elastin-Van Giemsa, x 450; 
Lumen - Upper center) 

XIV 
PHOTOGRAPH 5: Day 21 control. The myointimal hyperplasia per¬ 
sists, but has lessened. Medial edema is still evident. (Hema¬ 
toxylin and Eosin, x 450; Lumen - Left third) 
PHOTOGRAPH 6: Day 28 control. Only a minimal amount of intimal 




PHOTOGRAPH 7: Day 21 aspirin. The myointimal hyperplasia is mas¬ 
sive, nearly occluding the lumen. (Hematoxylin and Eosin, x 100; 
Lumen - Upper right) 
PHOTOGRAPH 8: Day 21 aspirin. Note the eccentricity of the in- 
timal thickening. (Elastin-Van Giemsa, x 100; Lumen - Upper right) 

XVI 
PHOTOGRAPH 9: Day 21 aspirin. A close-up view of the myointimal 
proliferation seen in Photographs 7 and 8. (Hematoxylin and Eosin, 
x 450; Lumen - Upper right 
PHOTOGRAPH 10: Day 14 aspirin, A localized pro!iferation of 
smooth muscle cells giving the appearance of an intraluminal 
polyp. (Hematoxylin and Eosin, x 100; Lumen - Center) 

xv i i 
PHOTOGRAPH 11: Day 14 aspirin. A close-up view of the 'polyp' 
seen in Photograph 10. (Hematoxylin and Eosin, x 450; Lumen - 
Left two-thirds) 
PHOTOGRAPH 12: Day 14 warfarin. Intimal thickening is evident 
but not especially pronounced. (Hematoxylin and Eosin, x 450; 
Lumen - Upper center) 

xvi i i 
PHOTOGRAPH 13: Day 14 warfarin. Only a minimal amount of intimal 
connective tissue is seen. (Elastin-Van Giemsa, x 450; Lumen - 
Upper right) 
PHOTOGRAPH 14: Day 28 warfarin. The intima is normal in appear¬ 
ance, showing no residual hyperplasia. (Hematoxylin and Eosin, 




PHOTOGRAPH 15: Day 28 warfarin. Note the absence of intimal 




PHOTOGRAPH 16: The set of instruments and materials used during 
the operative procedure. 
PHOTOGRAPH 17: Exposed cervical structures. The hemostats are 
retracting the submaxillary glands. The self-retaining retractor 
is separating the sternohyoid muscles. The tip of the forceps 
is on the left common carotid artery. The glistening structure 
in the midline is the trachea. 

xx i 
PHOTOGRAPH 18: The first ligature being threaded underneath 
the left common carotid artery. The artery is sitting on top 
of the hemostat just left of the trachea. 
PHOTOGRAPH 19: The needle-connecting tube-stopcock-syringe 
arrangement. The syringe on the left contains normal saline. 
The syringe on the right contains room air. The needle is 30-gauge. 

xx n 
PHOTOGRAPH 20: The desiccation procedure. The needle tip is 
in the vessel lumen. The vessel is manipulated via tension on 
the proximal (inferior) ligature. The distal ligature is seen 
exiting the wound superiorly. 
PHOTOGRAPH 21: Hemostasis is acheived with gentle pressure from 
a 4 x 4 gauze sponge. 

xx i i i 
PHOTOGRAPH 22: The finished product. Approximately two-thirds 
of the rats undergoing the procedure were left with a left Horner's 
Syndrome. Otherwise complete recovery was acheived within twenty- 
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